Ketamine Treatment for Pediatric-Refractory Obsessive-Compulsive Disorder (OCD)

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

5

Participants

Timeline

Start Date

March 31, 2015

Primary Completion Date

February 21, 2018

Study Completion Date

July 31, 2020

Conditions
Obsessive-Compulsive Disorder
Interventions
DRUG

Ketamine

Single infusion of IV Ketamine, 0.5mg/kg

Trial Locations (1)

10032

New York State Psychiatric Institute/Columbia University, New York

All Listed Sponsors
collaborator

New York Presbyterian Hospital

OTHER

lead

New York State Psychiatric Institute

OTHER

NCT02422290 - Ketamine Treatment for Pediatric-Refractory Obsessive-Compulsive Disorder (OCD) | Biotech Hunter | Biotech Hunter